Biocon Ltd. - Research Center
532523 BIOCON Group (A) BSE data
Results
Statement
More
| Mar ' 26 |
Mar ' 25 |
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Equity share capital
| 810.50 |
600.30 |
600.30 |
600.30 |
600.30 |
Share application money
Preference share capital
Reserves & surplus
| 26,268.40 |
10,923.20 |
10,311.10 |
10,314.80 |
7,491.70 |
Secured loans
| 1,150.30 |
2,871.00 |
2,040.80 |
1,297.70 |
75.90 |
Unsecured loans
Total
| 28,229.20 |
14,394.50 |
12,952.20 |
12,212.80 |
8,167.90 |
Gross block
| 3,063.40 |
2,675.20 |
2,429.60 |
2,338.10 |
2,144.80 |
Less : revaluation reserve
Less : accumulated depreciation
| 1,682.30 |
1,561.70 |
1,471.20 |
1,376.70 |
1,274.60 |
Net block
| 1,380.20 |
1,112.60 |
957.50 |
960.50 |
869.30 |
Capital work-in-progress
| 541.10 |
701.30 |
559.60 |
343.50 |
284.90 |
Investments
| 24,977.70 |
11,382.60 |
9,318.50 |
9,270.70 |
5,280.00 |
Current assets, loans & advances
| 2,370.70 |
2,423.70 |
2,931.70 |
2,454.30 |
2,433.90 |
Less : current liabilities & provisions
| 1,040.50 |
1,225.70 |
815.10 |
816.20 |
700.20 |
Total net current assets
| 1,330.20 |
1,198.00 |
2,116.60 |
1,638.10 |
1,733.70 |
Miscellaneous expenses not written
Total
| 28,229.20 |
14,394.50 |
12,952.20 |
12,212.80 |
8,167.90 |
Book value of unquoted investments
| 22,794.20 |
9,377.40 |
7,247.90 |
7,199.20 |
2,614.70 |
Market value of quoted investments
| 8,470.30 |
15,428.50 |
15,475.60 |
13,096.50 |
16,871.80 |
Contingent liabilities
| 1,035.40 |
1,081.40 |
1,125.30 |
754.80 |
638.30 |
Number of equity sharesoutstanding (Lacs)
| 16209.08 |
12006.00 |
12006.00 |
12006.00 |
12006.00 |